Literature DB >> 14556776

Dyskeratosis congenita: its link to telomerase and aplastic anaemia.

Inderjeet Dokal1, Tom Vulliamy.   

Abstract

Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome exhibiting considerable clinical and genetic heterogeneity. X-linked recessive, autosomal dominant and autosomal recessive forms are recognised. The gene mutated in X-linked DC (DKC1) encodes a highly conserved nucleolar protein called dyskerin. Dyskerin associates with the H/ACA class of small nucleolar RNAs which are important in guiding the conversion of uracil to pseudouracil in ribosomal RNA. Dyskerin also associates with the RNA component of telomerase (hTR) which is important in the maintenance of telomeres. Mutations in hTR were recently demonstrated in patients with autosomal dominant DC and in a subset of patients with aplastic anaemia (AA) but without other diagnostic features of DC. This discovery demonstrates that both DC and a subset of AA are due to a defect in telomerase. The link between DC and AA and in turn to defective telomerase suggests that treatments directed at correction of telomerase activity might benefit DC/AA patients who do not respond to conventional therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556776     DOI: 10.1016/s0268-960x(03)00020-1

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  36 in total

Review 1.  Cancer stem cells: relevance to clinical transplantation.

Authors:  Gabriel Ghiaur; Jonathan M Gerber; William Matsui; Richard J Jones
Journal:  Curr Opin Oncol       Date:  2012-03       Impact factor: 3.645

2.  Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.

Authors:  Hunter Hoffman; Cory Rice; Emmanuel Skordalakes
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

3.  Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells.

Authors:  Rodrigo T Calado; William T Yewdell; Keisha L Wilkerson; Joshua A Regal; Sachiko Kajigaya; Constantine A Stratakis; Neal S Young
Journal:  Blood       Date:  2009-06-26       Impact factor: 22.113

Review 4.  Ribosomopathies: human disorders of ribosome dysfunction.

Authors:  Anupama Narla; Benjamin L Ebert
Journal:  Blood       Date:  2010-03-01       Impact factor: 22.113

Review 5.  Maintenance of telomere length in AML.

Authors:  Peter M Lansdorp
Journal:  Blood Adv       Date:  2017-11-28

6.  The neuroradiological findings in a case of Revesz syndrome.

Authors:  Meir H Scheinfeld; Yvonne W Lui; Edward A Kolb; Harry M Engel; William A Gomes; Karen M Weidenheim; Jacqueline A Bello
Journal:  Pediatr Radiol       Date:  2007-09-14

7.  Short telomeres are sufficient to cause the degenerative defects associated with aging.

Authors:  Mary Armanios; Jonathan K Alder; Erin M Parry; Baktiar Karim; Margaret A Strong; Carol W Greider
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

8.  Cancer Stem Cells: From Bench to Bedside.

Authors:  Richard J Jones; William Matsui
Journal:  Biol Blood Marrow Transplant       Date:  2007-01       Impact factor: 5.742

Review 9.  Syndromes of telomere shortening.

Authors:  Mary Armanios
Journal:  Annu Rev Genomics Hum Genet       Date:  2009       Impact factor: 8.929

10.  Single-molecule analysis of the human telomerase RNA.dyskerin interaction and the effect of dyskeratosis congenita mutations.

Authors:  Beth Ashbridge; Angel Orte; Justin A Yeoman; Michael Kirwan; Tom Vulliamy; Inderjeet Dokal; David Klenerman; Shankar Balasubramanian
Journal:  Biochemistry       Date:  2009-11-24       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.